Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
Kazakhstan to produce pharmaceuticals for AstraZeneca
AstraZeneca has been represented in Kazakhstan for over 15 years
- By Newsdesk
- London
- Feb 27, 2023
Kazakhstan has signed a memorandum of understanding with the British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca.
“As part of the Kazakh President's election campaign, it was mandated to increase pharmaceutical output in Kazakhstan by up to 50%. The corresponding memorandum was signed with AstraZeneca,” said Timur Sultangaziyev, the country's first health vice minister.
“Approximately 40 pharmaceuticals have been approved. It is planned to import another 15 innovative pharmaceuticals and manufacture four types of pharmaceuticals,” said Alexander Tarishkin, Director of AstraZeneca's Kazakhstan Office.
AstraZeneca's UK Corporate Government Affairs Director, David Boyd, expressed the company's willingness to collaborate with the Kazakh government. AstraZeneca, which will initially establish its operations in Kazakhstan, plans on constructing its own plants in the country.